Processing of medical
cannabis-based substances
and preparations
As an EU-GMP processing unit dedicated to medical cannabis, Portocanna drives the sector’s growth in Europe. From Santarém, our operations address the requirements of GACP cultivators and ensure access to high-quality therapeutic solutions for thousands of patients through an international distribution network.
Portocanna specializes in the industrial processing of medical cannabis. By investing in certified pharmaceutical operations, biotechnology expertise, and advanced supply chain management, we collaborate with strategic partners to deliver pharmaceutical-grade products to patients across the European market.
Symbiosis is the most intelligent form of life
The Medical Cannabis industry developed from local markets that faced heavy regulation. This reality created vertically integrated, centralized businesses that focus on a Seed-to Sale strategy. Today, as demand increases and this industry earns growing recognition, we believe that it is now critical to maximize efficiency gains in every link in the value chain.
By creating a large symbiotic network of specialized growers, distributors, and innovators in Europe, we will speed the evolution of the industry and bring patients improved access to the highest quality cannabis-derived products.
PRODUCT
+ Diversity
+ Delivery Methods
+ IP Access
RISK MITIGATION
+ Quality Assurance
+ Procurement Network
+ Handling
ECONOMICALLY
+ SCALE
– RISK
WHO WE ARE
The company was founded by entrepreneurs with complementary backgrounds in medical cannabis and biotechnology, supported by a team with extensive experience in EU pharmaceutical operations and specific expertise in extract production.
Our strategy is backed by international Family Offices with a track record of investing in high-capitalization global operations within the healthcare and life sciences sectors.
WHO WE ARE
The company was founded by entrepreneurs with complementary backgrounds in medical cannabis and biotechnology, supported by a team with extensive experience in EU pharmaceutical operations and specific expertise in extract production.
Our strategy is backed by international Family Offices with a track record of investing in high-capitalization global operations within the healthcare and life sciences sectors.
ASSETS
Focusing on the processing link of the value chain, we invested in a 3,000sqm EU-GMP certified facility in Portugal comprised of:
• Fully equipped post-harvest processing room
• Dedicated quality control lab
• Certified extraction facility
• Large-scale packaging lines
• Large warehousing capacity
CAPABILITIES
With the diverse, highly specialized experiences of our team members and the symbiotic partnerships we have developed, we are building:
• Efficient operational processes
• Vast IP of strains & growers
• Strict pharma-grade SOPs
• Proprietary extraction methodologies
• Unique formulations
Our Partnerships
Complementing our network of local and international growers and distributors, we position ourselves in the the epicentrum of medical Cannabis knowledge and opportunity, creating partnerships with trusted and knowledgeable institutions and companies to share wisdom and design the sustainable future of this industry
Co-financed by:
CANNVALUE project
The CANNVALUE project, part of the SIID – Business R&D – Co-promotion initiative, is led by Portocanna in partnership with Universidade de Aveiro, ISQ (Instituto da Soldadura e Qualidade), and IPMA (Instituto Português do Mar e da Atmosfera, I.P.). The project’s goal is to promote efficiency and sustainability in the medicinal cannabis industry, taking a leading role in the implementation of environmentally sustainable practices.
For more details about the project, download the full document here.